Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
Chia Tai Tianqing Pharmaceutical Group Co Ltd — Human Necessities
Chia Tai Tianqing Pharmaceutical Group Co Ltd holds 338 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Chia Tai Tianqing Pharmaceutical Group Co Ltd |
| Technology | Human Necessities |
| Patents in slice | 338 |
| Recent patents in slice | 118 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Chia Tai Tianqing Pharmaceutical Group Co Ltd to Human Necessities.
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Recent filings
Latest patents from Chia Tai Tianqing Pharmaceutical Group Co Ltd in Human Necessities.
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
Related pages
Navigate to parent entity pages.